Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPP404 for Weight Loss in Overweight or Obese Subjects
NCT01540864Phase 2Terminated
- Sponsor
- High Point Pharmaceuticals LLC
- Start
- May 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HPP404 in obesity, Overweight, sponsored by High Point Pharmaceuticals LLC. Started May 2012; status: terminated.
02
Drugs
HPP404
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT01540864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540864.